Dextromethorphan and memantine in painful diabetic neuropathy and postherpetic neuralgia: Efficacy and dose-response trials

Anesthesiology

Volumn 96, Issue 5, 2002, Pages 1053-1061

  Sang, Christine N ^a   Booher, Susan ^b   Gilron, Ian ^c   Parada, Suzan ^b   Max, Mitchell B ^d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c QUEEN S UNIVERSITY   (Canada)

^d NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTROMETHORPHAN; LORAZEPAM; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PLACEBO;

ADULT; AGED; ANALGESIA; ANOREXIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIABETIC NEUROPATHY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG TOLERABILITY; FEMALE; HUMAN; MALE; NAUSEA; PAIN ASSESSMENT; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VOMITING;

ADULT; AGED; DEXTROMETHORPHAN; DIABETIC NEUROPATHIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; ENDPOINT DETERMINATION; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; HERPESVIRIDAE INFECTIONS; HUMANS; MALE; MEMANTINE; MIDDLE AGED; NEURALGIA; PAIN; PAIN MEASUREMENT; QUALITY OF LIFE; RECEPTORS, N-METHYL-D-ASPARTATE; TREATMENT OUTCOME;

EID: 0036235004     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200205000-00005     Document Type: Article

References (45)

1. MK-801 blocks the development of thermal hyperalgesia in a rat model of experimental painful neuropathy
2. Modulation of neuropathic pain behavior in rats by spinal disinhibition and NMDA receptor blockade of injury discharge
3. Intrathecal MK-801 and local nerve anesthesia synergistically reduce nociceptive behaviors in rats with experimental peripheral mononeuropathy
4. Spinal pharmacology of thermal hyperesthesia induced by constriction injury of sciatic nerve: Excitatory amino acid antagonists
5. Dextrorphan relieves neuropathic heat-evoked hyperalgesia in the rat
6. Comparison of the effects of MK-801, ketamine and memantine on responses of spinal dorsal horn neurones in a rat model of mononeuropathy
7. The NMDA-receptor antagonist CPP abolishes neurogenic 'wind-up pain' after intrathecal administration in humans
8. Relief of postherpetic neuralgia with the N-methyl-aspartic acid receptor antagonist ketamine: A double-blind, cross-over comparison with morphine and placebo
9. The effect of ketamine on phantom pain: A central neuropathic disorder maintained by peripheral input
10. NMDA receptor blockade in chronic neuropathic pain: A comparison of ketamine and magnesium chloride
11. Response of chronic neuropathic pain syndromes to ketamine: A preliminary study
12. High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia
13. A randomized, controlled trial of high-dose dextromethorphan in facial neuralgias
14. The NMDA (N-methyl-aspartate) receptor antagonist memantine in the treatment of postherpetic neuralgia: A double blind, placebo-controlled study
15. Memantine (a N-methyl-D-aspartate receptor antagonist) in the treatment of neuropathic pain after amputation or surgery: A randomized, double-blinded, cross-over study
16. Dextromethorphan and dextrorphan as calcium channel antagonists
17. Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine: Therapeutic advantage against NMDA receptor-mediated neurotoxicity
18. The clinically tested N-methyl-D-aspartate receptor antagonist memantine blocks and reverses thermal hyperalgesia in a rat model of painful mononeuropathy
19. Treatment with the NMDA antagonist memantine attenuates nociceptive responses to mechanical stimulation in neuropathic rats
20. Efficacy of spinal NMDA receptor antagonism in formalin hyperalgesia and nerve injury evoked allodynia in the rat
21. Amantadine and memantine are NMDA receptor antagonists with neuroprotective properties
22. Ratio scales of sensory and affective verbal pain descriptors
23. Transdermal clonidine compared to placebo in painful diabetic neuropathy using a two-stage 'enriched enrollment' design
24. Efficacy of pharmacological treatments of neuropathic pain: An update and effect related to mechanism of drug action
25. Threats to the validity of clinical trials employing enrichment strategies for sample selection
26. Dose-response and registration of new drugs
27. Neuropathic pain, The Design of Analgesic Clinical Trials
28. Dextromethorphan for the treatment of neuropathic pain: A double-blind randomised controlled crossover trial with integral n-of-1 design
29. Memantine in the treatment of diabetic peripheral neuropathy: A placebo-controlled phase IIB trial
30. Pain in peripheral neuropathy related to rate and kind of fiber degeneration
31. Pathophysiology of damaged nerves in relation to chronic pain
32. Therapeutic potential of excitatory amino acid antagonists: Channel blockers and 2,3-benzodiazepines
33. Dose escalation safety and tolerance study of the N-methyl-D-aspartate antagonist dextromethorphan in neurosurgery patients
34. Histological findings after long-term infusion of intrathecal ketamine for chronic pain: A case report
35. Selective NMDA NR2B antagonists induce antinociception without motor dysfunction: Correlation with restricted localisation of NR2B subunit in dorsal horn
36. Antinociceptive activity of CP-101,606, an NMDA receptor NR2B subunit antagonist
37. Intraplantar injection of dextrorphan, ketamine or memantine attenuates formalin-induced behaviors
38. Dextromethorphan: An overview of safety issues
39. The influence of CYP2D6 polymorphism and quinidine on the disposition and antitussive effectof dextromethorphan in humans
40. Dextromethorphan: Enhancing its systemic availability by way of low-dose quinidine-mediated inhibition of cytochrome P4502D6
41. Clinically relevant pharmacology of selective serotoninreuptake inhibitors: An overview with emphasis of pharmacokinetics and effects on oxidative drug metabolism
42. Drug interactions in human neuropathic pain pharmacotherapy
43. Serotonin syndrome
44. Dextromethorphan-induced manic symptoms in a bipolar patient on lithium